Effects of lianhuang decoction in treating fetomaternal ABO blood group incompatibility.
- Author:
Zhu-Hua CAI
1
;
Ying-Yi CHEN
;
Jue ZENG
Author Information
- Publication Type:Journal Article
- MeSH: ABO Blood-Group System; Adult; Blood Group Incompatibility; drug therapy; Drugs, Chinese Herbal; therapeutic use; Female; Humans; Infant, Newborn; Jaundice, Neonatal; prevention & control; Phytotherapy; Pregnancy; Young Adult
- From: Chinese Journal of Integrated Traditional and Western Medicine 2009;29(2):156-158
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the clinical curative effect of Lianhuang Decoction (LHD) in treating fetomaternal ABO blood group incompatibility (FM-ABOI).
METHODSSixty pregnancy women diagnosed as FM-ABOI were randomly assigned to two groups, Group A treated with LHD and Group B treated with Western medicine. The therapeutic efficacy in the two groups was observed.
RESULTSThe antibody titer decreased after treatment in both groups to different extent; the effective rate was 90.0% in Group A and 56.7% in Group B. The bilirubin level in cord blood of Group A was lower than that in Group B significantly (P<0.01). No statistically significant difference was found between the two groups new-bom in terms of 5-minute Apgar score, body weight and hemoglobin content in cord blood (P>0.05).
CONCLUSIONLHD has good clinical curative effect in treating FM-ABOI, could decrease the serum antibody titer, and prevent the occurrence of postpartum hemolytic disease in newborns.
